Efficacy of immunoliposomes on cancer models in a cell-surface-antigen- density-dependent manner

British Journal of Cancer

Volumn 89, Issue 8, 2003, Pages 1545-1551

  Hosokawa, S ^a,d   Tagawa, T ^a,d   Niki, H ^a   Hirakawa, Y ^a   Nohga, K ^b   Nagaike, K ^c,d  

^a MITSUBISHI KAGAKU INSTITUTE OF LIFE SCIENCES   (Japan)

^b KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^c MITSUBISHI CHEMICAL CORPORATION   (Japan)

^d TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Doxorubicin; Human monoclonal antibody; Immunoliposomes; Polyethyleneglycol; Targeting

Indexed keywords

DOXORUBICIN; IMMUNOLIPOSOME; MACROGOL; MEMBRANE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER MODEL; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG TARGETING; HUMAN; HUMAN CELL; INTERNALIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DOXORUBICIN; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOTHERAPY; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; POLYETHYLENE GLYCOLS; SOLVENTS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0242407091     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601341     Document Type: Article

References (30)

1. Aamdal S, Fodstad O, Nesland JM, Pihl A (1985) Characteristic of human tumor xenografts transplanted under the renal capsule of immunocompetent mice. Br J Cancer 51: 347-356
2. Ahmad I, Longenecker M, Samuel J, Allen TM (1993) Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res 53: 1484-1488
3. Bator JM, Reading CL (1991) Antibody-mediated Cancer Diagnosis and Therapy. Therapeutic Monoclonal Antibodies, Borrebaeck CAK, Larride, JW (eds) pp 35-56. New York: Stockton Press
4. Bennett JA, Pilon VA, MacDowell RT (1985) Evaluation of growth and histology of human tumor xenografts implanted under the renal capsule of immunocompetent and immunodeficient mice. Cancer Res 45: 4963-4969
5. Ditzel HJ, Garrigues U, Andersen CB, Larsen MK, Garrigues HJ, Svejgaard A, Hellstrom I, Hellstrom KE, Jensenius JC (1997) Modified cytokeratins expressed on the surface of carcinoma cells undergo endocytosis upon binding of human monoclonal antibody and its recombinant Fab fragment. Proc Natl Acad Sci USA 94: 8110-8115
6. Gabizon A (1992) Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 52: 891-896
7. Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A, Barenholz Y (1994) Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54: 987-992
8. Geran R, Greenberg N, MacDonald M, Schmacner A, Abott B (1972) Protocols for screening chemical agents and natural product against animal tumors and other biological systems. Cancer Chemother Res 3: 1-85
9. Green LM, Reade JL, Ware CF (1984) Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods 70: 257-268
10. Horan PK, Melnicoff MJ, Jensen BD, Slezak SE (1990) Fluorescent cell labeling for in vivo and in vitro cell tracking. Methods Cell Biol 33: 469-490
11. Hosokawa S, Hirakawa Y, Niki H, Tagawa T, Nagaike K (2001) Establishment of human monoclonal antibody (hu-McAb) GAH, exhibiting a specific reactivity to viable cancer cells from fresh tissues and evaluation of the use of antibody GAH in targeting cancer therapy. Proceedings of the 92nd Annual Meeting of the American Association for Cancer Research, Vol. 42, 137 (737) New Orleans, Louisiana, USA
12. Huang SK, Lee KD, Hong K, Friend DS, Papahadjopoulos D (1992) Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res 52: 5135-5143
13. Huwyler J, Yang J, Pardridge WM (1997) Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat. J Pharmacol Exp Ther 282: 1541-1546
14. Kirpotin D, Park JW, Hong K, Zalipsky S, Li WL, Carter P, Benz CC, Papahadjopoulos D (1997) Sterically stabilized anti-her2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Biochemistry 36: 66-75
15. Konno H, Suzuki H, Tadakuma T, Kumai K, Yasuda T, Kubota T, Ohta S, Nagaike K, Hosokawa S, Ishibiki K, Abe O, Saito K (1987) Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody. Cancer Res 47: 4471-4477
16. Laverman P, Dams ET, Storm G, Hafmans TG, Croes HJ, Oyen WJ, Corstens FH, Boerman OC (2001) Microscopic localization of peg-liposomes in a rat model of focal infection. J Control Rel 75: 347-355
17. Li X, Hirsh DJ, Cabral-Lilly D, Zirkel A, Gruner SM, Janoff AS, Perkins WR (1998) Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient. Biochim Biophys Acta 1415: 23-40
18. Maruyama K, Takahashi N, Tagawa T, Nagaike K, Iwatsuru M (1997) Immunoliposomes bearing polyethyleneglycol-coupled Fab′ fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo. FEBS Lett 413: 177-180
19. Mayer LD, Bally MB, Hope MJ, Cullis PR (1985) Uptake of antineoplastic agents into large unilamella vesicles in response to a membrane potential. Biochim Biophys Acta 816: 294-302
20. Nasoff MS, Gu M, Galindo J, He XM, Mukerjee S, McKnight M, Glassy MC (1997) Cloning and expression of the human tumor-specific antibody gm4. Hybridoma 16: 427-439
21. Nichols JW, Deamer DW (1976) Catecholamine uptake and concentration by liposomes maintaining pH gradients. Biochim Biophys Acta 455: 269-271
22. Papadimitriou E, Antimisiaris SG (2000) Interactions of pc/chol and ps/chol liposomes with human cells in vitro. J Drug Target 8: 335-351
23. Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, Lee KD, Woodle MC, Lasic DD, Redemann C, Martin FJ (1991) Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 88: 11460-11464
24. Park JW, Hong K, Carter P, Asgari H, Guo LY, Keller GA, Wirth C, Shalaby R, Kotts C, Wood WI, Papahadjopoulos D, Benz CC (1995) Development of anti-p185her2 immunoliposomes for cancer therapy. Proc Natl Acad Sci USA 92: 1327-1331
25. Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC (2002) Anti-her2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin Cancer Res 8: 1172-1181
26. Park JW, Hong K, Kirpotin DB, Papahadjopoulos D, Benz CC (1997) Immunoliposomes for cancer treatment. Adv Pharmacol 40: 399-435
27. Suzuki S, Inoue K, Hongoh A, Hashimoto Y, Yamazoe Y (1997) Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor. Br J Cancer 76: 83-89
28. Suzuki S, Watanabe S, Masuko T, Hashimoto Y (1995) Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol). Biochim Biophys Acta 1245(1): 9-16
29. Traut RR, Bollen A, Sun TT, Hershey JW, Sundberg J, Pierce LR (1973) Methyl 4-mercaptobutyrimidate as a cleavable cross-linking reagent and its application to the Escherichia coli 30s ribosome. Biochemistry 12: 3266-3273
30. Uyama I, Kumai K, Yasuda T, Tagawa T, Ishibiki K, Kitajima M, Tadakuma T (1994) Improvement of therapeutic effect by using Fab′ fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes. Jpn J Cancer Res 85: 434-440